Cold allodynia and hyperalgesia in neuropathic pain: The effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine - A double-blind, cross-over comparison with alfentanil and placebo

Pain

Volumn 101, Issue 3, 2003, Pages 229-235

  Jorum E ^a   Warncke, T ^a   Stubhaug, A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cold allodynia hyperalgesia; Mechanical allodynia hyperalgesia; N methyl D aspartate receptor antagonist ketamine; Neuropathic pain; Ongoing pain; Opioid agonist alfentanil

Indexed keywords

ALFENTANIL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; FATIGUE; FEMALE; HEARING IMPAIRMENT; HEAT; HEAT SENSATION; HUMAN; HYPERALGESIA; MALE; MOOD; NAUSEA; NEUROPATHIC PAIN; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIZATION; SIDE EFFECT; SKIN TEMPERATURE; VERTIGO; VISUAL ANALOG SCALE; VISUAL DISORDER; XEROSTOMIA;

EID: 0037316640     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00122-7     Document Type: Article

References (21)

1. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Attal N., Gaude V., Brasseur L., Dupuy M., Guirimand F., Parker F., Bouhassira D. Intravenous lidocaine in central pain, a double-blind, placebo-controlled, psychophysical study. Neurology. 1:2000;564-574.
3. Dubner R., Ruda M.A. Activity dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
4. Eide P.K., Jørum E., Stubhaug A., Bremnes J., Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 58:1994;347-354.
5. Eide P.K., Stubhaug A., Stenehjem A. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery. 37:1995;1080-1087.
6. Felsby S., Nielsen J., Arendt-Nielsen L., Jensen T.S. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain. 64:1996;283-291.
7. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
8. Ilkjaer S., Petersen K.L., Brennum J., Wernberg M., Dahl J.B. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anesth. 76:1996;829-834.
9. Kristensen J.D., Svensson B., Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic "wind-up pain" after intrathecal administration in humans. Pain. 51:1992;249-253.
10. Lindblom U. Assessment of abnormal evoked pain in neurological pain patients and its relation to spontaneous pain: a descriptive and conceptual model with some analytical results. Adv Pain Res Ther. 9:1985;409-423.
11. Ochoa J.L., Yarnitsky D. The triple cold syndrome. Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease. Brain. 117:1994;185-197.
12. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 43:1990;273-286.
13. Rowbotham M.C., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 41:1991;1024-1028.
14. Schüttler J, Kloos S. IVA-SIM, version 3.0, Bonn; 1991.
15. Stubhaug A., Breivik H., Eide P.K., Kreunen M., Foss A. Mapping of punctate hyperalgesia surrounding a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitisation to pain following surgery. Acta Anaesthesiol Scand. 41:1997;1124-1132.
16. Wahren L.K., Torebjörk E., Jørum E. Central suppression of cold-induced C fibre pain by myelinated fibre input. Pain. 38:1989;313-319.
17. Warncke T., Stubhaug A., Jørum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 72:1997;99-106.
18. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet. 353:1999;1959-1964.
19. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitisation is dependent on N-methyl-D-aspartate acid receptor activity: implication for the treatment of post-injury pain hypersensitivity. Pain. 44:1991;293-299.
20. Woolf C.J., Bennett G.J., Doherty M., Dubner R., Kidd B., Koltzenburg M., Lipton R., Loeser J.D., Payne R., Torebjörk E. Towards a mechanism-based classification of pain? Pain. 77:1998;227-229.
21. Yarnitsky D., Ochoa J.L. Release of cold-induced burning pain by block of cold-specific afferent input. Brain. 113:1990;893-902.